Shares of other companies:
Wall Street Brunch: Here Comes Nvidia
May 19, 2024
A.O. Smith: Great Company, Inferior Investment
May 18, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
ABT Stock News and Mentions of Abbott Laboratories Stocktwits
Updated: May 20, 2024 (09:13)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Abbott Laboratories Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Abbott Laboratories (ABT).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Abbott Laboratories stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Abbott Laboratories (ABT)
May 16, 2024 (14:00) / "Benzinga" (by Globe Newswire)
Sepsis Diagnostics Market Surges to USD 891.05 Million by 2031, Propelled by 7% CAGR - Verified Market Research®
Lewes, Delaware, May 16, 2024 ( GLOBE NEWSWIRE ) -- The Global Sepsis Diagnostics Market is projected to grow at a CAGR of 7% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
May 16, 2024 (12:00) / "Motley Fool" (by George Budwell)
These Dividend Stocks Are an Investor's Best Friend
These two healthcare stocks are well-known for their top-tier dividend programs.
In Article Trend: Bullish
May 16, 2024 (11:30) / "GlobeNewswire" (by CVRx)
CVRx Announces Key Senior Leadership Team Hires
MINNEAPOLIS, May 16, 2024 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( "CVRx" ) , a commercial-stage medical device company, today announced three additions to its senior leadership team. Philip B. Adamson, MD, MSc, FACC, FESC, FRCP ( Ed ) has been appointed as Chief Medical Officer, ...
In Article Trend: Somewhat-Bullish
May 15, 2024 (15:02) / "Benzinga" (by Benzinga Insights)
Massive Insider Trade At Abbott Laboratories - Abbott Laboratories ( NYSE:ABT )
Revealing a significant insider sell on May 14, Robert E. Funck Jr., Executive Vice President at Abbott Laboratories ABT, as per the latest SEC filing. What Happened: Jr.'s recent move involves selling 10,097 shares of Abbott Laboratories. This information is documented in a Form 4 filing with ...
In Article Trend: Somewhat-Bullish
May 14, 2024 (17:45) / "Benzinga" (by Benzinga Insights)
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories ( NYSE:ABT )
Whales with a lot of money to spend have taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 27% of the investors opened trades with ...
In Article Trend: Somewhat-Bullish
May 14, 2024 (11:45) / "Forbes" (by CFP(R))
5 Best Dividend Stocks To Help Hedge Inflation
As inflation seems to be sticking around with rates above 3%, investors seek refuge in assets that can offer stability and growth. Dividend stocks, known for their consistent payouts and potential for capital appreciation, emerge as a compelling option in turbulent economic times.
In Article Trend: Bullish
May 13, 2024 (11:00) / "PR Newswire" (by Inc.)
Senhwa Biosciences Announces Jason Huang, MD as New Chief Medical Officer
NEW TAIPEI CITY, May 13, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. ( TPEx: 6492 ) , announced the appointment of Jason Huang, M.D., former Regional Therapeutic Area Expert ( RTAE ) , Janssen, a subsidiary of Johnson and Johnson, as the company's chief medical officer.
In Article Trend: Somewhat-Bullish
May 10, 2024 (20:18) / "Benzinga" (by Benzinga Insights)
What the Options Market Tells Us About Abbott Laboratories - Abbott Laboratories ( NYSE:ABT )
Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish ...
In Article Trend: Somewhat-Bullish
May 10, 2024 (13:30) / "Motley Fool" (by David Jagielski)
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
These are low-risk stocks with high yields.
In Article Trend: Somewhat-Bullish
May 10, 2024 (13:30) / "Investors Business Daily" (by Investor's Business Daily)
Q&A: This New CEO Has Big Ideas For A Small Biotech
Catalyst Pharmaceuticals CEO Richard Daly: Big Plans For The Small Biotech Stock Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
May 9, 2024 (15:54) / "CNBC" (by Morgan Chittum)
Here's why we scooped up additional shares of these 2 lagging health-care stocks
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
In Article Trend: Somewhat-Bullish
May 9, 2024 (12:35) / "Benzinga" (by Avi Kapoor)
Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling - Amazon.com ( NASDAQ:AMZN )
The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.
In Article Trend: Neutral
May 8, 2024 (10:18) / "Zacks Commentary" (by Zacks Investment Research)
The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips are included in this Analyst Blog.
In Article Trend: Somewhat-Bullish
May 7, 2024 (11:10) / "GlobeNewswire" (by BioPorto A/S)
BioPorto A/S Appoints President and CEO of BioPorto Inc.
May 7, 2024News release ...
In Article Trend: Somewhat-Bullish
May 6, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Patient Monitoring Devices Market is Expected to Reach $71.1 billion | MarketsandMarkets™
Chicago, May 06, 2024 ( GLOBE NEWSWIRE ) -- Patient Monitoring Devices market in terms of revenue was estimated to be worth $48.5 billion in 2024 and is poised to reach $71.1 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029 according to a latest report published by MarketsandMarkets™.
In Article Trend: Bullish
May 5, 2024 (17:44) / "Motley Fool" (by Prosper Junior Bakiny)
3 Reasons to Buy AbbVie Stock on the Dip
A little patience with the drugmaker should pay off.
In Article Trend: Somewhat-Bullish
May 3, 2024 (13:15) / "Benzinga" (by Benzinga Insights)
How Is The Market Feeling About Abbott Laboratories? - Abbott Laboratories ( NYSE:ABT )
Abbott Laboratories's ABT short percent of float has fallen 7.69% since its last report. The company recently reported that it has 14.48 million shares sold short, which is 0.84% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
May 2, 2024 (14:00) / "Benzinga" (by Globe Newswire)
Molecular Biology Enzymes And Kits And Reagents Market Surges to USD 69.4 Billion by 2031, Propelled by 17.35% CAGR - Verified Market Research®
Lewes, Delaware, May 02, 2024 ( GLOBE NEWSWIRE ) -- The Global Molecular Biology Enzymes And Kits And Reagents Market is projected to grow at a CAGR of 17.35% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
May 1, 2024 (20:46) / "Benzinga" (by Benzinga Insights)
What the Options Market Tells Us About Abbott Laboratories - Abbott Laboratories ( NYSE:ABT )
Deep-pocketed investors have adopted a bullish approach towards Abbott Laboratories ABT, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
In Article Trend: Somewhat-Bullish
April 28, 2024 (11:45) / "Motley Fool" (by Prosper Junior Bakiny)
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
These companies aren't in danger of becoming has-beens.
In Article Trend: Somewhat-Bullish
April 28, 2024 (08:20) / "Motley Fool" (by Prosper Junior Bakiny)
Better Dividend Stock: AbbVie or Johnson & Johnson?
One thing is for sure: Dividend seekers can't go wrong with either.
In Article Trend: Somewhat-Bullish
April 27, 2024 (11:15) / "Motley Fool" (by Keith Speights)
3 Dividend Stocks to Buy and Hold for the Next Decade
You'll get dividends and more with these great stocks.
In Article Trend: Somewhat-Bullish
April 25, 2024 (12:21) / "Zacks Commentary" (by Zacks Equity Research)
3 Diamond Hill Mutual Funds for Higher Returns
Invests in Diamond Hill mutual funds like DHLSX, DHLTX and DHLAX for diversified investment opportunities across various asset classes.
In Article Trend: Somewhat-Bullish
April 24, 2024 (19:53) / "CNBC" (by Kevin Stankiewicz)
Here's a rapid-fire update on all 33 portfolio stocks including our tech giants reporting this week
During the Investing Club's Monthly Meeting on Wednesday, Jim Cramer offered his updated thinking on the stocks in the portfolio.
In Article Trend: Neutral
April 23, 2024 (15:36) / "Zacks Commentary" (by Zacks Equity Research)
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
In Article Trend: Somewhat-Bullish
April 19, 2024 (16:51) / "Investors Business Daily" (by IBD STAFF)
Stock Market Shows Bearish Action: Weekly Review
Stock Market Sells Off. Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review Investor's Business Daily ...
In Article Trend: Neutral
April 19, 2024 (12:30) / "Investors Business Daily" (by Investor's Business Daily)
Dexcom In Buy Zone After Launch Of Prescription-Free Diabetes Monitor; Earnings Due Next Week
Dexcom Stock Is In Buy Zone Ahead Of Earnings Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
April 18, 2024 (21:31) / "PR Newswire" (by DelveInsight Business Research)
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness.
In Article Trend: Neutral
April 18, 2024 (17:31) / "Benzinga" (by Benzinga Insights)
Behind the Scenes of Abbott Laboratories's Latest Options Trends - Abbott Laboratories ( NYSE:ABT )
Investors with significant funds have taken a bearish position in Abbott Laboratories ABT, a development that retail traders should be aware of. This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga.
In Article Trend: Somewhat-Bullish
April 17, 2024 (15:26) / "Fox Business News" (by Daniella Genovese)
Heart pumps tied to 14 deaths, hundreds of injuries are being recalled
Nearly 14,000 heart pumps tied to hundreds of injuries and more than a dozen deaths are being recalled, according to federal health officials.
In Article Trend: Neutral
April 17, 2024 (15:04) / "Zacks Commentary" (by Zacks Equity Research)
Q1 Earnings Review
Pre-market futures are up slightly at this hour. Markets look to rebound off a three-day losing streak on the S&P 500 and Nasdaq. the blue-chip Dow outperformed the field yesterday, closing +0.17%. Major indices are all lower over the past month, from -1.7% ( tech-heavy Nasdaq ) to -2.9% ( ...
In Article Trend: Neutral
April 17, 2024 (14:32) / "Zacks Commentary" (by Mark Vickery)
Markets Try to Shake Off April Blues
Late March highs -- including all-time S&P levels -- have given way to profit-taking and existential concerns.
In Article Trend: Neutral
April 17, 2024 (14:30) / "Benzinga" (by Globe Newswire)
Blood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 17, 2024 ( GLOBE NEWSWIRE ) -- The Global Blood Collection Market is projected to grow at a CAGR of 5.10% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 17, 2024 (14:13) / "Zacks Commentary" (by Zacks Equity Research)
Abbott ( ABT ) Q1 Earnings Beat Estimates, Margins Contract
Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
In Article Trend: Somewhat-Bullish
April 17, 2024 (14:07) / "Benzinga" (by Avi Kapoor)
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings - Abbott Laboratories ( NYSE:ABT ) , Edible Garden AG ( NASDAQ:EDBL )
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ rose 0.24% to 15,903.38. The S&P 500 also rose, gaining, 0.40% to 5,071.74.
In Article Trend: Somewhat-Bullish
April 17, 2024 (12:46) / "CNBC" (by Jeff Marks)
We're buying a health-care stock that should be higher after reporting a strong quarter
It's the third time in recent weeks that we've added to our position in the medical device maker.
In Article Trend: Somewhat-Bullish
April 17, 2024 (12:42) / "Benzinga" (by Vandana Singh)
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance - Abbott Laboratories ( NYSE:ABT )
Wednesday, Abbott Laboratories ABT reported first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion. Reported sales increased by 2.2%, which includes the anticipated decline in COVID-19 testing-related revenue ...
In Article Trend: Somewhat-Bullish
April 17, 2024 (11:52) / "Investors Business Daily" (by Investor's Business Daily)
Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance
Abbott stock see-sawed early Wednesday after the giant health care company reported adjusted income of 98 cents a share on $10 billion in first-quarter sales. The Street projected earnings of 95 cents a share and $9.88 billion in sales, according to FactSet.
In Article Trend: Somewhat-Bullish
April 17, 2024 (11:09) / "Benzinga" (by Shanthi Rexaline)
S&P 500, Nasdaq Futures Point To Higher Open Today: What's Going On? - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )
U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far in April. As some bullish market watchers pointed out there could be an inflection from the second half of April, with earnings potentially serving as an upside catalyst.
In Article Trend: Neutral
April 17, 2024 (06:06) / "Benzinga" (by Avi Kapoor)
Investor Optimism Decreases; Dow Ends 6-Session Losing Streak - Abbott Laboratories ( NYSE:ABT ) , Bank of America ( NYSE:BAC )
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear" zone on Tuesday. U.S. stocks closed mixed on Tuesday amid increased geopolitical concerns. The Dow Jones index, meanwhile, snapped its six-session losing streak.
In Article Trend: Somewhat-Bearish
April 17, 2024 (06:06) / "Benzinga" (by Avi Kapoor)
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday - Abbott Laboratories ( NYSE:ABT ) , U.S. Bancorp ( NYSE:USB )
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Abbott Laboratories ABT to report quarterly earnings at 95 cents per share on revenue of $9.88 billion before the opening bell, according to ...
In Article Trend: Somewhat-Bullish
April 16, 2024 (15:30) / "Kiplinger" (by Joey Solitro)
Why Is UNH Stock Soaring After Earnings?
UnitedHealth Group ( UNH ) stock is soaring over 5% in Tuesday's session after the company beat both earnings and revenue estimates for its fiscal 2024 first quarter. UNH stock can certainly use the boost considering it was down 15% for the year-to-date heading into today's trading.
In Article Trend: Bullish
April 16, 2024 (14:56) / "Zacks Commentary" (by Zacks Equity Research)
Bio-Rad ( BIO ) Hurt by Softness in BioPharma and Competition
Bio-Rad's (BIO) margin performance bears the brunt of elevated raw material costs, increased logistics costs and higher employee-related expenses.
In Article Trend: Neutral
April 16, 2024 (12:10) / "Forbes" (by Danielle Chemtob)
Daily: Samsung Overtakes Apple As iPhone Shipments Slump
Forbes Daily: Samsung overtakes Apple in smartphone shipments Forbes ...
In Article Trend: Neutral
April 16, 2024 (10:30) / "Forbes" (by Giacomo Tognini)
Inside The Collapse Of A Former Billionaire's Foundation For Low-Income Students
Healthcare Investor Shuts Down Scholarship Program Forbes ...
In Article Trend: Neutral
April 15, 2024 (08:14) / "The Financial Express"
Page 40320 of
Ambuja Realty Group has entered into the education sector, taking over Institute of Technology and Marine Engineering, although it would… Most human resource managers try to serenade the 18-25 year olds, the Generation Y, by either money or promise of…
In Article Trend: Neutral
April 14, 2024 (11:30) / "CNN" (by Bryan Mena)
Americans are savings less these days. Here's why and what that means | Business
Americans are saving less these days. Here's why and what that means ...
In Article Trend: Neutral
April 14, 2024 (05:23) / "Motley Fool" (by Alex Carchidi)
Is AbbVie a Millionaire Maker?
Everything is going according to plan, and more growth is on the way.
In Article Trend: Somewhat-Bullish
April 13, 2024 (03:33) / "PR Newswire" (by 360iResearch)
STD Testing Market Projected to Reach $14.11 billion by 2030 - Exclusive Report by 360iResearch
PUNE, India, April 12, 2024 /PRNewswire/ -- The report titled "STD Testing Market by Type ( Blood Tests, Lumbar Puncture, Swab Tests ) , Product Type ( Instruments, Reagents & Kits ) , Test Settings, Indication, End-user - Global Forecast 2024-2030" is now available on 360iResearch.com's ...
In Article Trend: Bullish
April 13, 2024 (00:57) / "Zacks Commentary" (by Shaun Pruitt)
3 Buy Rated Stocks to Consider as Earnings Approach
Several top-rated Zacks stocks are standing out before their first-quarter earnings report next week and here are three to consider.
In Article Trend: Somewhat-Bullish
April 12, 2024 (13:51) / "Zacks Commentary" (by Zacks Equity Research)
What's in Store for Abbott Laboratories ( ABT ) in Q1 Earnings?
Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.
In Article Trend: Somewhat-Bullish
April 12, 2024 (12:43) / "Benzinga" (by Avi Kapoor)
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer - Abbott Laboratories ( NYSE:ABT ) , Cummins ( NYSE:CMI )
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc. NFE, but "right now Wes Edens [co-founder of Fortress Investment Group and founder of New Fortress Energy] is kind of just hurt by the president."
In Article Trend: Somewhat-Bullish
April 11, 2024 (18:31) / "Benzinga" (by Benzinga Insights)
Abbott Laboratories Unusual Options Activity - Abbott Laboratories ( NYSE:ABT )
Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish ...
In Article Trend: Somewhat-Bullish
April 11, 2024 (13:31) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) Sphere-360 PFA Study Outcome Favorable
Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.
In Article Trend: Somewhat-Bullish
April 11, 2024 (10:15) / "Motley Fool" (by Prosper Junior Bakiny)
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
These companies provide stability, reliability, and passive income.
In Article Trend: Somewhat-Bullish
April 9, 2024 (13:10) / "Benzinga" (by Avi Kapoor)
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse' - Abbott Laboratories ( NYSE:ABT ) , Emerson Electric ( NYSE:EMR )
On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories ABT over Penumbra, Inc. PEN. "I still fear it after the environmental damage. I am concerned that you can't really put a price on it," Cramer said when asked about Hawaiian Electric Industries, Inc.
In Article Trend: Neutral
April 9, 2024 (10:45) / "Motley Fool" (by Adam Spatacco)
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate.
In Article Trend: Somewhat-Bullish
April 9, 2024 (08:21) / "Motley Fool" (by Cory Renauer)
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
In Article Trend: Somewhat-Bullish
April 8, 2024 (14:10) / "Zacks Commentary" (by Zacks Equity Research)
Abbott ( ABT ) Faces Low Testing Demand, Currency Headwinds
Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
In Article Trend: Somewhat-Bullish
April 8, 2024 (13:13) / "Zacks Commentary" (by Zacks Equity Research)
The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services
T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks top Analyst Blog.
In Article Trend: Somewhat-Bullish
April 5, 2024 (20:55) / "Zacks Commentary" (by Sheraz Mian)
Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
In Article Trend: Bullish
April 5, 2024 (13:52) / "Zacks Commentary" (by Zacks Equity Research)
Abbott ( ABT ) Receives FDA's Approval for the TriClip TEER System
Abbott (ABT) receives FDA nod for TriClip, a first-of-its-kind device to repair a leaky tricuspid heart valve.
In Article Trend: Somewhat-Bullish
April 4, 2024 (08:47) / "Benzinga" (by Benzinga Neuro)
Is Your Smartphone The Future Of Heart Disease Detection? This Finnish Startup Thinks So
CardioSignal, a Finnish startup, has developed a system that uses smartphone motion sensors to detect heart disease. This innovation is a significant breakthrough in the health tech industry.
In Article Trend: Bullish
April 3, 2024 (15:30) / "Benzinga" (by Globe Newswire)
Transformative Growth Expected In The Global Medical Equipment Market: Market Size To Reach $1,077 Billion By 2028 As Per The Business Research Company's Medical Equipment Global Market Report 2024
LONDON, April 03, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Medical Equipment Global Market Report 2024, the medical equipment market has witnessed robust growth in recent years, with the market size expected to reach $775.42 billion in 2024, reflecting a compound annual ...
In Article Trend: Somewhat-Bullish
April 3, 2024 (10:20) / "Zacks Commentary" (by Zacks Equity Research)
Should You Invest in the iShares U.S. Medical Devices ETF ( IHI ) ?
Sector ETF report for IHI ...
In Article Trend: Somewhat-Bullish
April 2, 2024 (17:00) / "Benzinga" (by Vandana Singh)
FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries - Abbott Laboratories ( NYSE:ABT )
Tuesday, the FDA approved Abbott Laboratories' ABT first-of-its-kind TriClip transcatheter edge-to-edge repair ( TEER ) system that's specifically designed to treat tricuspid regurgitation ( TR ) , or a leaky tricuspid valve.
In Article Trend: Somewhat-Bullish
April 2, 2024 (15:18) / "Zacks Commentary" (by Zacks Equity Research)
Abbott's ( ABT ) i-STAT TBI Cartridge Receives FDA Approval
Abbott's (ABT) i-STAT Alinity instrument uses whole blood to help assess patients with a suspected mild traumatic brain injury or concussion.
In Article Trend: Neutral
April 2, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Electroceuticals/Bioelectric Medicine Market is Expected to Reach $33.6 billion | MarketsandMarkets™
Chicago, April 02, 2024 ( GLOBE NEWSWIRE ) -- Electroceuticals/Bioelectric Medicine market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (10:30) / "Benzinga" (by PRNewswire)
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors - Elanco Animal Health ( NYSE:ELAN )
New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee GREENFIELD, Ind., April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated ELAN today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors ( ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (10:30) / "PR Newswire" (by Elanco Animal Health)
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee
In Article Trend: Somewhat-Bullish
April 1, 2024 (10:20) / "Zacks Commentary" (by Zacks Equity Research)
Should You Invest in the Invesco Pharmaceuticals ETF ( PJP ) ?
Sector ETF report for ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (08:30) / "Motley Fool" (by Prosper Junior Bakiny)
Meet The "Magnificent Seven" of Healthcare Stocks
The tech sector doesn't have a monopoly on magnificent corporations.
In Article Trend: Somewhat-Bullish
March 30, 2024 (09:19) / "Motley Fool" (by Cory Renauer)
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
These advantaged businesses have what it takes to keep raising their payouts.
In Article Trend: Somewhat-Bullish
March 28, 2024 (18:00) / "Benzinga" (by Benzinga Insights)
How Is The Market Feeling About Abbott Laboratories? - Abbott Laboratories ( NYSE:ABT )
Abbott Laboratories's ABT short percent of float has risen 12.16% since its last report. The company recently reported that it has 14.29 million shares sold short, which is 0.83% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
March 27, 2024 (16:25) / "Zacks Commentary" (by Zacks Equity Research)
Abbott's ( ABT ) Assert-IQ Cardiac Monitor Receives CE Mark
Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
In Article Trend: Somewhat-Bullish
March 27, 2024 (15:00) / "Benzinga" (by Benzinga Insights)
Performance Comparison: Abbott Laboratories And Competitors In Health Care Equipment & Supplies Industry - Abbott Laboratories ( NYSE:ABT )
In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Abbott Laboratories ABT and its primary competitors in the ...
In Article Trend: Somewhat-Bullish
March 26, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Abbott Laboratories ( ABT ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Abbott Laboratories (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In Article Trend: Somewhat-Bullish
March 25, 2024 (06:00) / "Business Insider" (by markets.businessinsider.com)
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
Paris, France and Munich, Germany, March 25, 2024 - TRiCares SAS ( "TRiCares" ) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer ( CEO ) .
In Article Trend: Somewhat-Bullish
March 25, 2024 (00:55) / "Business Insider" (by Nicolás Jose Rodriguez)
Verano Holdings CIO To Share Insights Into Florida's Cannabis Boom At Benzinga Conference
Amidst the buzz of potential recreational legalization and federal cannabis rescheduling, comprehending cannabis stock dynamics is vital for investors. Florida's burgeoning market offers a unique chance for those poised to seize emerging opportunities.
In Article Trend: Bullish
March 25, 2024 (00:33) / "Benzinga" (by Nicolás Jose Rodriguez)
Verano Holdings CIO To Share Insights Into Florida's Cannabis Boom At Conference - Verano Holdings ( OTC:VRNOF )
Amidst the buzz of potential recreational legalization and federal cannabis rescheduling, comprehending cannabis stock dynamics is vital for investors. Florida's burgeoning market offers a unique chance for those poised to seize emerging opportunities. At Verano Holdings Inc.
In Article Trend: Bullish
March 22, 2024 (16:18) / "PR Newswire"
Pharmaceuticals Market In Germany size is set to grow by USD 21.44 bn from 2023-2027, Abbott Laboratories, AbbVie ... - PR Newswire
Pharmaceuticals Market In Germany size is set to grow by USD 21.44 bn from 2023-2027, Abbott Laboratories, AbbVie ... PR ...
In Article Trend: Somewhat-Bullish
March 22, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Point of Care Diagnostics Market is Expected to Reach $77.8 billion | MarketsandMarkets™
Chicago, March 22, 2024 ( GLOBE NEWSWIRE ) -- Point of Care Diagnostics market in terms of revenue was estimated to be worth $49.7 billion in 2023 and is poised to reach $77.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
March 22, 2024 (08:25) / "Motley Fool" (by Prosper Junior Bakiny)
Want Decades of Passive Income? 2 Stocks to Buy Now.
There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.
In Article Trend: Somewhat-Bullish
March 21, 2024 (15:00) / "Forbes" (by Bruce Japsen)
Diabetes Monitoring Apps Don't Deliver Meaningful Benefits, Report Says
Digital diabetes management tools "fail to deliver meaningful benefits to patients" while at the same time increasing the cost of healthcare to consumers, health insurers and taxpayers, a new report finds.
In Article Trend: Somewhat-Bullish
March 21, 2024 (13:09) / "CNBC" (by Jeff Marks)
We're buying more of this health-care company amid an overdone sell-off
The company has lost billions in market capitalization over the past few trading sessions.
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website